Human Complement Serum - May 31, 2017

Posted by Leanne Kodsman on

May 31, 2017 Innovative Research's Single Donor Human Complement Serum was recently used in the following study:

Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

Lukmanee Tradtrantip, Xiaoming Yao, Tao Su, Alex J. Smith, Alan S. Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 °C for specified times. ...

  • Tags: Human Serum, Single Donor Human Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Innovative Research’s Role in Developing a Zero-Gravity Versatile Sample Preparation Platform (VSPP)
    The realm of space exploration continually seeks innovations that can enhance the safet...
    Read the Article
    We have biological products and research materials to assist with early phase next gen COVID vaccine research
    This autumn, as clinical trials get underway to evaluate the effectiveness of the most ...
    Read the Article
    Monoclonal Antibody to VLDLR (MA-1H10): An Explainer
    The Innovative Research lab pulled together an explainer on one of our recently popular...
    Read the Article

    ← Older Post Newer Post →

    ×